A similar study on a different human ovarian cancer line (SKOV-3) revealed that esculetin treatment dose-dependently upregulated the apoptosis-linked proteins Bax, cytochrome C, and cleaved caspases-3 and -9. Here, BAX is linked to ovarian carcinoma.